Patients with metastatic ccRCC and rhabdoid dedifferentiation had a high frequency of genomic alterations in BAP1 (n = 3/4) and SETD2 (n = 2/4). The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.